HM-97662

N/A

Report date: 2022/10/31 20:01:01
NME

Base Information

Drug NameHM-97662
Drug Alias NameHM-97662
ClassificationOther
Mechanisms of ActionHistone-lysine N-methyltransferase EZH1 inhibitors
TargetsHistone-lysine N-methyltransferase EZH1
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaSouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHanmi Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A